Bubolz Aaron H, Li Hongwei, Wu Qingping, Liu Yanping
Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
Am J Physiol Heart Circ Physiol. 2005 Nov;289(5):H1873-80. doi: 10.1152/ajpheart.00357.2005. Epub 2005 Jun 3.
We have shown that short-term exposure of rat small coronary arteries (RSCAs) to high glucose enhances superoxide (O2-) formation and impairs cAMP-mediated dilation by reducing voltage-gated K+ (Kv) channel function. However, it is not clear whether the impairment also occurs in diabetes mellitus (DM), where alternate mechanisms could mask or aggravate vasodilator dysfunction. RSCAs were isolated from control and streptozotocin-induced diabetic rats. Reduced constriction to 4-aminopyridine (4-AP) was observed in RSCAs from DM rats, indicating Kv channel impairment. Forskolin increased 4-AP-inhibitable K+ channel open-state probability and whole cell K+ current density in coronary myocytes from non-DM rats but had little effect on K+ current density in cells from DM rats. Diminished dilation to 8-bromo-cAMP, forskolin, or isoproterenol was observed in DM RSCAs. The attenuated dilation to forskolin or isoproterenol in DM RSCAs was partially restored by application of the superoxide dismutase mimetic manganese[III] tetrakis (4-benzoic acid) porphyrin. Histofluorescence studies using hydroethidine revealed a blockage of O2- generation by the NADPH oxidase inhibitor apocynin in DM RSCAs. Sepiapterin, a precursor of tetrahydrobiopterin, had little effect on hyperglycemia-induced O2-* formation. Consistent with the findings from the concurrent fluorescence study, apocynin also partially restored the reduced dilator response to forskolin in DM RSCAs. Forskolin-induced cAMP production was unaltered in DM. We conclude that in diabetes, enhanced O2-* formation by activation of NADPH oxidase impairs cAMP-medicated dilation in RSCAs by inhibiting Kv channel activity.
我们已经表明,大鼠小冠状动脉(RSCA)短期暴露于高葡萄糖会增强超氧化物(O2-*)的形成,并通过降低电压门控钾离子(Kv)通道功能来损害cAMP介导的血管舒张。然而,尚不清楚这种损害在糖尿病(DM)中是否也会发生,在糖尿病中,其他机制可能会掩盖或加重血管舒张功能障碍。从对照大鼠和链脲佐菌素诱导的糖尿病大鼠中分离出RSCA。在糖尿病大鼠的RSCA中观察到对4-氨基吡啶(4-AP)的收缩反应降低,表明Kv通道受损。福斯高林增加了非糖尿病大鼠冠状动脉心肌细胞中4-AP可抑制的钾离子通道开放状态概率和全细胞钾离子电流密度,但对糖尿病大鼠细胞中的钾离子电流密度影响很小。在糖尿病RSCA中观察到对8-溴-cAMP、福斯高林或异丙肾上腺素的舒张反应减弱。通过应用超氧化物歧化酶模拟物锰[III]四(4-苯甲酸)卟啉,部分恢复了糖尿病RSCA中对福斯高林或异丙肾上腺素减弱的舒张反应。使用氢乙啶的组织荧光研究表明,NADPH氧化酶抑制剂夹竹桃麻素可阻断糖尿病RSCA中O2-*的产生。四氢生物蝶呤的前体蝶酰三谷氨酸对高血糖诱导的O2-*形成几乎没有影响。与同时进行的荧光研究结果一致,夹竹桃麻素也部分恢复了糖尿病RSCA中对福斯高林降低的舒张反应。福斯高林诱导的cAMP产生在糖尿病中未改变。我们得出结论,在糖尿病中,通过激活NADPH氧化酶增强的O2-*形成通过抑制Kv通道活性损害了RSCA中cAMP介导的舒张功能。